APA

Maoz M., Devir M., Inbar M., Inbar-Daniel Z., Sherill-Rofe D., Bloch I., Meir K., Edelman D., Azzam S., Nechushtan H., Maimon O., Uziely B., Kadouri L., Sonnenblick A., Eden A., Peretz T. & Zick A. (20201106). Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes. : Scientific reports.

Chicago

Maoz Myriam, Devir Michal, Inbar Michal, Inbar-Daniel Ziva, Sherill-Rofe Dana, Bloch Idit, Meir Karen, Edelman David, Azzam Salah, Nechushtan Hovav, Maimon Ofra, Uziely Beatrice, Kadouri Luna, Sonnenblick Amir, Eden Amir, Peretz Tamar and Zick Aviad. 20201106. Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes. : Scientific reports.

Harvard

Maoz M., Devir M., Inbar M., Inbar-Daniel Z., Sherill-Rofe D., Bloch I., Meir K., Edelman D., Azzam S., Nechushtan H., Maimon O., Uziely B., Kadouri L., Sonnenblick A., Eden A., Peretz T. and Zick A. (20201106). Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes. : Scientific reports.

MLA

Maoz Myriam, Devir Michal, Inbar Michal, Inbar-Daniel Ziva, Sherill-Rofe Dana, Bloch Idit, Meir Karen, Edelman David, Azzam Salah, Nechushtan Hovav, Maimon Ofra, Uziely Beatrice, Kadouri Luna, Sonnenblick Amir, Eden Amir, Peretz Tamar and Zick Aviad. Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes. : Scientific reports. 20201106.